A detailed history of High Tower Advisors, LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, High Tower Advisors, LLC holds 15,397 shares of COLL stock, worth $461,910. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,397
Previous 15,145 1.66%
Holding current value
$461,910
Previous $487,000 21.97%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$31.4 - $39.07 $7,912 - $9,845
252 Added 1.66%
15,397 $594,000
Q2 2024

Aug 13, 2024

SELL
$31.36 - $39.99 $14,519 - $18,515
-463 Reduced 2.97%
15,145 $487,000
Q1 2024

May 06, 2024

BUY
$31.23 - $40.91 $487,437 - $638,523
15,608 New
15,608 $605,000
Q4 2022

Feb 08, 2023

BUY
$16.14 - $23.55 $316,279 - $461,485
19,596 New
19,596 $454,000

Others Institutions Holding COLL

About COLLEGIUM PHARMACEUTICAL, INC


  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.02B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.